{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:00:07Z","timestamp":1792785607609,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Leiden University Medical Center, Leiden, The Netherlands","id":[{"id":"https:\/\/ror.org\/05xvt9f17","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.cytogfr.2011.08.001","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T18:34:41Z","timestamp":1316111681000},"page":"221-229","source":"Crossref","is-referenced-by-count":89,"title":["Bone morphogenetic protein 7: A broad-spectrum growth factor with multiple target therapeutic potency"],"prefix":"10.1016","volume":"22","author":[{"given":"Mari\u00ebtte R.","family":"Boon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertje","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabri","family":"van der Pluijm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouke T.","family":"Tamsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes W.A.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.N.","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2011.08.001_bib0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11154-006-9000-6","article-title":"Bone morphogenetic proteins and their antagonists","volume":"7","author":"Gazzerro","year":"2006","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1359-6101(97)00036-1","article-title":"Signal transduction by bone morphogenetic proteins","volume":"9","author":"Kawabata","year":"1998","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.150.3698.893","article-title":"Bone: formation by autoinduction","volume":"150","author":"Urist","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cytogfr.2009.10.007","article-title":"Recent advances in BMP receptor signaling","volume":"20","author":"Sieber","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0025","article-title":"Bone morphogenetic proteins: a critical review","author":"Bragdon","year":"2010","journal-title":"Cell Signal"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/jmbi.1999.2590","article-title":"Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution","volume":"287","author":"Scheufler","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jcp.1080","article-title":"Divergence and convergence of TGF-beta\/BMP signaling","volume":"187","author":"Miyazono","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0040","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1158\/0008-5472.CAN-06-2490","article-title":"Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer","volume":"67","author":"Buijs","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0045","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.V12112392","article-title":"Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy","volume":"12","author":"Wang","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0050","doi-asserted-by":"crossref","first-page":"13377","DOI":"10.1016\/S0021-9258(18)80003-5","article-title":"partial amino acid sequence of osteogenin, a protein initiating bone differentiation","volume":"264","author":"Luyten","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0055","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1073\/pnas.84.20.7109","article-title":"Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography","volume":"84","author":"Sampath","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0060","doi-asserted-by":"crossref","first-page":"9484","DOI":"10.1073\/pnas.85.24.9484","article-title":"Purification and characterization of other distinct bone-inducing factors","volume":"85","author":"Wang","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0065","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.3201241","article-title":"Novel regulators of bone formation: molecular clones and activities","volume":"242","author":"Wozney","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0070","doi-asserted-by":"crossref","first-page":"20352","DOI":"10.1016\/S0021-9258(19)88709-4","article-title":"Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro","volume":"267","author":"Sampath","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0075","doi-asserted-by":"crossref","first-page":"8793","DOI":"10.1073\/pnas.86.22.8793","article-title":"Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin","volume":"86","author":"Vukicevic","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0080","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/00003086-199810001-00008","article-title":"Initiation of fracture repair by bone morphogenetic proteins","author":"Reddi","year":"1998","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0085","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/00003086-199810001-00003","article-title":"The cell and molecular biology of fracture healing","author":"Einhorn","year":"1998","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0090","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1445-2197.2007.04175.x","article-title":"Bone morphogenetic proteins in clinical applications","volume":"77","author":"Gautschi","year":"2007","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00003086-200402000-00003","article-title":"Nonunion: general principles and experimental data","author":"Rodriguez-Merchan","year":"2004","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0100","first-page":"2","article-title":"Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model","volume":"30","author":"Cook","year":"1994","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0105","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2106\/00004623-199406000-00006","article-title":"The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects","volume":"76","author":"Cook","year":"1994","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0110","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2106\/00004623-199505000-00010","article-title":"Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates","volume":"77","author":"Cook","year":"1995","journal-title":"J Bone Joint Surg Am"},{"issue":"Suppl 1:","key":"10.1016\/j.cytogfr.2011.08.001_bib0115","first-page":"S151","article-title":"Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions","volume":"83-A","author":"Friedlaender","year":"2001","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00402-009-0982-x","article-title":"Clinical application of BMP 7 in long bone non-unions","volume":"130","author":"Moghaddam","year":"2010","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0125","first-page":"6","article-title":"Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair","volume":"2","author":"Wozney","year":"1998","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1517\/14740338.4.1.75","article-title":"Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects","volume":"4","author":"Harwood","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0135","unstructured":"Prevalence of disabilities and associated health conditions among adults \u2013 United States, 1999. MMWR Morb Mortal Wkly Rep 2001;50:120\u20135."},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0140","first-page":"1037","article-title":"Management of common musculoskeletal problems: a survey of Ontario primary care physicians","volume":"158","author":"Glazier","year":"1998","journal-title":"CMAJ"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrrheum.2010.197","article-title":"The bone-cartilage unit in osteoarthritis","volume":"7","author":"Lories","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0150","first-page":"103","article-title":"Regulation of anabolic and catabolic gene expression in normal and osteoarthritic adult human articular chondrocytes by osteogenic protein-1","volume":"22","author":"Fan","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0155","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/art.1780391117","article-title":"Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes","volume":"39","author":"Flechtenmacher","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0160","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.joca.2004.01.008","article-title":"Osteogenic Protein-1 inhibits matrix depletion in a hyaluronan hexasaccharide-induced model of osteoarthritis","volume":"12","author":"Nishida","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0165","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/art.1780401209","article-title":"Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1beta","volume":"40","author":"Huch","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s000110050446","article-title":"Osteogenic protein-1 (OP-1) blocks cartilage damage caused by fibronectin fragments and promotes repair by enhancing proteoglycan synthesis","volume":"48","author":"Koepp","year":"1999","journal-title":"Inflamm Res"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0175","doi-asserted-by":"crossref","first-page":"25386","DOI":"10.1074\/jbc.M302048200","article-title":"Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes","volume":"278","author":"Im","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0180","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1006\/bbrc.1993.2612","article-title":"Bovine articular chondrocytes do not undergo hypertrophy when cultured in the presence of serum and osteogenic protein-1","volume":"197","author":"Chen","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 1","key":"10.1016\/j.cytogfr.2011.08.001_bib0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1242\/jcs.108.1.105","article-title":"Osteogenic protein-1 promotes growth and maturation of chick sternal chondrocytes in serum-free cultures","volume":"108","author":"Chen","year":"1995","journal-title":"J Cell Sci"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1006\/bbrc.1994.1100","article-title":"Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity binding to basement membranes","volume":"198","author":"Vukicevic","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/002215540004800209","article-title":"Human articular chondrocytes express osteogenic protein-1","volume":"48","author":"Chubinskaya","year":"2000","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0200","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0925-4439(02)00158-8","article-title":"Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1)","volume":"1588","author":"Chubinskaya","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0205","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0736-0266(03)00055-X","article-title":"Alterations in endogenous osteogenic protein-1 with degeneration of human articular cartilage","volume":"21","author":"Merrihew","year":"2003","journal-title":"J Orthop Res"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0210","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/art.20856","article-title":"Antisense inhibition of osteogenic protein 1 disturbs human articular cartilage integrity","volume":"52","author":"Soder","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0215","first-page":"23","article-title":"Regeneration of articular cartilage defects in rabbits by osteogenic protein-1 (bone morphogenetic protein-7)","volume":"51","author":"Grgic","year":"1997","journal-title":"Acta Med Croatica"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0220","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1097\/00003086-200010001-00023","article-title":"Cartilage and bone regeneration using gene-enhanced tissue engineering","author":"Mason","year":"2000","journal-title":"Clin Orthop Relat Res"},{"issue":"Suppl. 3","key":"10.1016\/j.cytogfr.2011.08.001_bib0225","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2106\/00004623-200300003-00018","article-title":"Repair of articular cartilage defects with osteogenic protein-1 (BMP-7) in dogs","volume":"85-A","author":"Cook","year":"2003","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/08977190109001079","article-title":"Regeneration of articular cartilage chondral defects by osteogenic protein-1 (bone morphogenetic protein-7) in sheep","volume":"19","author":"Jelic","year":"2001","journal-title":"Growth Factors"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0235","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/(SICI)1097-4636(20000315)49:4<506::AID-JBM9>3.0.CO;2-A","article-title":"Use of recombinant human osteogenic protein-1 for the repair of subchondral defects in articular cartilage in goats","volume":"49","author":"Louwerse","year":"2000","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0240","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2474-11-232","article-title":"Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis","volume":"11","author":"Hunter","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0245","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0250","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1172\/JCI200318899","article-title":"TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression","volume":"112","author":"Tang","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0255","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2353\/ajpath.2007.070168","article-title":"BMP7 a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo","volume":"171","author":"Buijs","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0260","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/pros.2990240406","article-title":"Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells","volume":"24","author":"Harris","year":"1994","journal-title":"Prostate"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0265","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00467-002-0988-x","article-title":"Diabetic nephropathy: renal development gone awry?","volume":"18","author":"Dolan","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0270","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1073\/pnas.93.17.9021","article-title":"Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7)","volume":"93","author":"Vukicevic","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0275","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1101\/gad.9.22.2795","article-title":"A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye","volume":"9","author":"Dudley","year":"1995","journal-title":"Genes Dev"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0280","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1523-1755.2002.00103.x","article-title":"BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells","volume":"61","author":"Gould","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0290","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.0959-9673.2004.00377.x","article-title":"Smad3 as a mediator of the fibrotic response","volume":"85","author":"Flanders","year":"2004","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0295","first-page":"991","article-title":"Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease","volume":"74","author":"Kopp","year":"1996","journal-title":"Lab Invest"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0300","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1046\/j.1523-1755.2000.00420.x","article-title":"Renal fibrosis in mice treated with human recombinant transforming growth factor-beta2","volume":"58","author":"Ledbetter","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0305","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1073\/pnas.120055097","volume":"97","author":"Ziyadeh","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0310","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ki.1996.65","article-title":"Expression of transforming growth factor-beta isoforms in human glomerular diseases","volume":"49","author":"Yamamoto","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0315","first-page":"82","article-title":"Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase","volume":"144","author":"Marti","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0320","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1681\/ASN.V991629","article-title":"Differential regulation of matrix metalloproteinases and their inhibitors in human glomerular epithelial cells in vitro","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0325","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI0215518","article-title":"Evidence that fibroblasts derive from epithelium during tissue fibrosis","volume":"110","author":"Iwano","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0330","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000147748","article-title":"An overview of epithelio-mesenchymal transformation","volume":"154","author":"Hay","year":"1995","journal-title":"Acta Anat (Basel)"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0335","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","article-title":"Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis","volume":"176","author":"Humphreys","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0340","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","article-title":"Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney","volume":"173","author":"Lin","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0345","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1681\/ASN.2008121226","article-title":"New insights into epithelial\u2013mesenchymal transition in kidney fibrosis","volume":"21","author":"Liu","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0350","article-title":"The origin of interstitial myofibroblasts in chronic kidney disease","author":"Grgic","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0355","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s00467-005-1927-4","article-title":"Downregulation of the expression of bone morphogenetic protein 7 in experimental pyelonephritis","volume":"20","author":"Biyikli","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0360","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.90.5.1814","article-title":"Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy","volume":"90","author":"Yamamoto","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0365","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0370","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.molmed.2005.09.007","article-title":"BMP7 signaling in renal development and disease","volume":"11","author":"Patel","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0375","doi-asserted-by":"crossref","first-page":"23200","DOI":"10.1074\/jbc.M311998200","article-title":"Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0380","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1172\/JCI2237","article-title":"Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat","volume":"102","author":"Vukicevic","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0385","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1046\/j.1523-1755.2003.00035.x","article-title":"Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy","volume":"63","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0390","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.mnh.0000133974.24935.fe","article-title":"Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease","volume":"13","author":"Li","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0395","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0400","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cmet.2010.03.008","article-title":"Human brown adipose tissue","volume":"11","author":"Enerback","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0405","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0410","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa0808718","article-title":"Cold-activated brown adipose tissue in healthy men","volume":"360","author":"van Marken Lichtenbelt","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0415","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","article-title":"Functional brown adipose tissue in healthy adults","volume":"360","author":"Virtanen","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0420","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.tips.2009.05.003","article-title":"BAT: a new target for human obesity?","volume":"30","author":"Fruhbeck","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0425","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nature07182","article-title":"PRDM16 controls a brown fat\/skeletal muscle switch","volume":"454","author":"Seale","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0430","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1073\/pnas.0610615104","article-title":"Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages","volume":"104","author":"Timmons","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0435","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1074\/jbc.M109.053942","volume":"285","author":"Petrovic","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0440","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1073\/pnas.1010929108","article-title":"Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat","volume":"108","author":"Schulz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0445","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/nature07221","article-title":"New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure","volume":"454","author":"Tseng","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0450","doi-asserted-by":"crossref","first-page":"e17247","DOI":"10.1371\/journal.pone.0017247","article-title":"Brown adipose tissue in morbidly obese subjects","volume":"6","author":"Vijgen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0455","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1139\/y84-035","article-title":"Energy balance following sympathetic denervation of brown adipose tissue","volume":"62","author":"Dulloo","year":"1984","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0460","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2105\/AJPH.24.10.1045","article-title":"Use of dinitrophenol in nutritional disorders: a critical survey of clinical results","volume":"24","author":"Tainter","year":"1934","journal-title":"Am J Public Health Nations Health"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0465","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1467-789X.2001.00043.x","article-title":"Mitochondrial uncoupling as a target for drug development for the treatment of obesity","volume":"2","author":"Harper","year":"2001","journal-title":"Obes Rev"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0470","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2967\/jnumed.106.039065","article-title":"Effect of nicotine and ephedrine on the accumulation of 18F-FDG in brown adipose tissue","volume":"48","author":"Baba","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0475","doi-asserted-by":"crossref","first-page":"167S","DOI":"10.1093\/ajcn\/55.1.167s","article-title":"Metabolic consequences of fenfluramine for the control of body weight","volume":"55","author":"Levitsky","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0480","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0091-3057(85)90410-1","article-title":"Effect of fenfluramine on GDP-binding to brown adipose tissue mitochondria","volume":"23","author":"Lupien","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.cytogfr.2011.08.001_bib0485","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0091-3057(02)00857-2","article-title":"Sympathetic activation by fenfluramine depletes brown adipose tissue norepinephrine content in rats","volume":"73","author":"Subramanian","year":"2002","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610111000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610111000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T19:37:33Z","timestamp":1638646653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610111000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1359610111000414"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2011.08.001","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}